FDA.reportPublic FDA data

Janus Kinase Inhibitors

Class ID
N0000190857
Source
MEDRT
Type
MOA

RxNorm Concepts In This Class#

unique RxNorm concepts page 1 of 1 ยท 15 matching rows.

RxCUI, Display, Full name table
RxCUIDisplayFull nameTypeForm / route
1741046Tofacitinib XR (Oral Pill)24 HR tofacitinib 11 MG Extended Release Oral TabletSCD Active24 HR XR Tab / Oral Pill
1741049XELJANZ XR (Oral Pill)24 HR tofacitinib 11 MG Extended Release Oral Tablet [Xeljanz]SBD Active24 HR XR Tab / Oral Pill
1357536tofacitinibtofacitinibIN Active
1741044tofacitinib 11 MGtofacitinib 11 MGSCDC Active
1741047tofacitinib 11 MG [Xeljanz]tofacitinib 11 MG [Xeljanz]SBDC Active
1357537tofacitinib 5 MGtofacitinib 5 MGSCDC Active
1357543tofacitinib 5 MG [Xeljanz]tofacitinib 5 MG [Xeljanz]SBDC Active
1357541Tofacitinib (Oral Pill)tofacitinib 5 MG Oral TabletSCD ActiveTab / Oral Pill
1357547XELJANZ (Oral Pill)tofacitinib 5 MG Oral Tablet [Xeljanz]SBD ActiveTab / Oral Pill
1358492tofacitinib citratetofacitinib citratePIN Active
1741045tofacitinib Extended Release Oral Tablettofacitinib Extended Release Oral TabletSCDF Active
1741048tofacitinib Extended Release Oral Tablet [Xeljanz]tofacitinib Extended Release Oral Tablet [Xeljanz]SBDF Active
1357540tofacitinib Oral Tablettofacitinib Oral TabletSCDF Active
1357544tofacitinib Oral Tablet [Xeljanz]tofacitinib Oral Tablet [Xeljanz]SBDF Active
1357542XeljanzXeljanzBN Active